莱斯康制药(LXRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LXRX 莱斯康制药

未开盘 12-16 16:00:00 EST

1.20

-0.03

-2.44%

盘后1.21

+0.01+0.83%

19:57 EST

最高1.25	最低1.17	成交量169.43万
今开1.22	昨收1.23	日振幅6.50%
总市值4.36亿	流通市值2.21亿	总股本3.63亿
成交额203.88万	换手率0.92%	流通股本1.84亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LXRX","market":"US","secType":"STK","nameCN":"莱斯康制药","latestPrice":1.2,"timestamp":1765918800000,"preClose":1.23,"halted":0,"volume":1694288,"hourTrading":{"tag":"盘后","latestPrice":1.21,"preClose":1.2,"latestTime":"19:57 EST","volume":17608,"amount":21041.7582,"timestamp":1765933070756},"delay":0,"floatShares":183889453,"shares":363398680,"eps":-0.189102,"marketStatus":"未开盘","change":-0.03,"latestTime":"12-16 16:00:00 EST","open":1.22,"high":1.25,"low":1.17,"amount":2038778.9381711998,"amplitude":0.065041,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.189102,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765962000000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":955080000000,"exchange":"NASDAQ","adjPreClose":1.23,"preHourTrading":{"tag":"盘前","latestPrice":1.22,"preClose":1.23,"latestTime":"09:24 EST","volume":3312,"amount":4065.3041327999995,"timestamp":1765895066126},"postHourTrading":{"tag":"盘后","latestPrice":1.21,"preClose":1.2,"latestTime":"19:57 EST","volume":17608,"amount":21041.7582,"timestamp":1765933070756},"volumeRatio":1.262756,"impliedVol":1.5661,"impliedVolPercentile":0.5663},"requestUrl":"/m/hq/s/LXRX/wiki","defaultTab":"wiki","newsList":[{"id":"1155538128","title":"2025心血管临床试验论坛将发布Sotagliflozin在非糖尿病患者中对脂肪分布影响的临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1155538128","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155538128?lang=zh_cn&edition=full","pubTime":"2025-12-05 21:30","pubTimestamp":1764941414,"startTime":"0","endTime":"0","summary":"2025心血管临床试验论坛将发布Sotagliflozin在非糖尿病患者中对脂肪分布影响的临床数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXRX","BK4007","BK4139"],"gpt_icon":0},{"id":"1160642383","title":"莱斯康制药提交最高达7500万美元普通股发售申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1160642383","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160642383?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:02","pubTimestamp":1763571735,"startTime":"0","endTime":"0","summary":"11月7日 - 莱斯康制药 :: 莱斯康制药提交最高达7500万美元普通股发售申请 - SEC 文件","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","LXRX"],"gpt_icon":0},{"id":"1174691635","title":"莱斯康制药第三季度每股收益为-0.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1174691635","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174691635?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:57","pubTimestamp":1763571440,"startTime":"0","endTime":"0","summary":"11月6日 — 莱斯康制药第三季度基本每股收益为-0.04美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXRX","BK4007","BK4139"],"gpt_icon":0},{"id":"2582227804","title":"莱斯康制药盘中异动 股价大涨5.20%报1.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582227804","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582227804?lang=zh_cn&edition=full","pubTime":"2025-11-10 22:59","pubTimestamp":1762786796,"startTime":"0","endTime":"0","summary":"北京时间2025年11月10日22时59分，莱斯康制药股票出现异动，股价急速上涨5.20%。截至发稿，该股报1.32美元/股，成交量58.0686万股，换手率0.16%，振幅4.80%。莱斯康制药股票所在的生物技术行业中，整体涨幅为0.77%。消息层面，截至22时59分，《花旗维持莱斯康制药买入评级，维持目标价1.9美元》资讯为影响莱斯康制药的重要信息。根据TipRanks数据显示，该分析师近一年总胜率为41.7%，总平均回报率为5.3%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110225956a6efcaac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110225956a6efcaac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LXRX","BK4007","BK4139"],"gpt_icon":0},{"id":"2581533868","title":"莱斯康制药盘中异动 股价大跌5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581533868","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581533868?lang=zh_cn&edition=full","pubTime":"2025-11-07 22:46","pubTimestamp":1762526801,"startTime":"0","endTime":"0","summary":"北京时间2025年11月07日22时46分，莱斯康制药股票出现波动，股价快速跳水5.24%。截至发稿，该股报1.36美元/股，成交量39.2913万股，换手率0.11%，振幅3.85%。机构评级方面，在所有5家参与评级的机构中，60%的券商给予买入建议，40%的券商给予持有建议，无券商给予卖出建议。莱斯康制药股票所在的生物技术行业中，整体跌幅为0.62%。莱斯康制药公司简介：莱斯康制药有限公司是一家生物制药公司，从事用于治疗人类疾病的药品的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107224641a4909192&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107224641a4909192&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LXRX"],"gpt_icon":1},{"id":"2573988054","title":"莱斯康制药盘中异动 快速拉升5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2573988054","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573988054?lang=zh_cn&edition=full","pubTime":"2025-10-06 22:09","pubTimestamp":1759759749,"startTime":"0","endTime":"0","summary":"北京时间2025年10月06日22时09分，莱斯康制药股票出现波动，股价急速上涨5.67%。截至发稿，该股报1.49美元/股，成交量83.3328万股，换手率0.23%，振幅3.55%。机构评级方面，在所有5家参与评级的机构中，60%的券商给予买入建议，40%的券商给予持有建议，无券商给予卖出建议。莱斯康制药股票所在的生物技术行业中，整体跌幅为0.11%。莱斯康制药公司简介：莱斯康制药有限公司是一家生物制药公司，从事用于治疗人类疾病的药品的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100622091097218b5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100622091097218b5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LXRX"],"gpt_icon":0},{"id":"2572562045","title":"莱斯康制药盘中异动 股价大涨5.19%报1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572562045","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572562045?lang=zh_cn&edition=full","pubTime":"2025-10-01 21:38","pubTimestamp":1759325880,"startTime":"0","endTime":"0","summary":"北京时间2025年10月01日21时38分，莱斯康制药股票出现异动，股价急速拉升5.19%。截至发稿，该股报1.42美元/股，成交量39.6194万股，换手率0.11%，振幅5.93%。莱斯康制药股票所在的生物技术行业中，整体涨幅为1.44%。其相关个股中，Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Palisade Bio, Inc.、Alpha Cognition Inc.涨幅较大，Palisade Bio, Inc.、Scisparc Ltd.、Soligenix, Inc.较为活跃，换手率分别为183.16%、11.04%、10.41%，振幅较大的相关个股有Palisade Bio, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Leap Therapeutics, Inc.，振幅分别为23.26%、15.04%、13.22%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100121380094b73abf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100121380094b73abf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LXRX","BK4139"],"gpt_icon":1},{"id":"1169702810","title":"莱斯康制药宣布向美国FDA提交额外数据以支持Zynquista®在1型糖尿病治疗中获益风险评估的最新进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1169702810","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169702810?lang=zh_cn&edition=full","pubTime":"2025-09-23 04:00","pubTimestamp":1758571216,"startTime":"0","endTime":"0","summary":"莱斯康制药宣布向美国FDA提交额外数据以支持Zynquista®在1型糖尿病治疗中获益风险评估的最新进展","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXRX","BK4139"],"gpt_icon":0},{"id":"1187738885","title":"Pilavapadin在欧洲糖尿病研究协会(EASD)和Neurodiab年会上发表的数据显示，该药物能为成人糖尿病周围神经病变疼痛(DPNP)患者带来显著的疼痛缓解效果","url":"https://stock-news.laohu8.com/highlight/detail?id=1187738885","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187738885?lang=zh_cn&edition=full","pubTime":"2025-09-17 19:01","pubTimestamp":1758106882,"startTime":"0","endTime":"0","summary":"Pilavapadin在欧洲糖尿病研究协会(EASD)和Neurodiab年会上发表的数据显示，该药物能为成人糖尿病周围神经病变疼痛(DPNP)患者带来显著的疼痛缓解效果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXRX","BK4139"],"gpt_icon":0},{"id":"1188404725","title":"莱斯康制药宣布向美国FDA提交支持Zynquista®在1型糖尿病治疗中效益风险概况的额外数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1188404725","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188404725?lang=zh_cn&edition=full","pubTime":"2025-09-08 20:30","pubTimestamp":1757334620,"startTime":"0","endTime":"0","summary":"莱斯康制药宣布向美国FDA提交支持Zynquista®在1型糖尿病治疗中效益风险概况的额外数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXRX","BK4139"],"gpt_icon":0},{"id":"2564235913","title":"莱斯康制药盘中异动 早盘股价大涨5.91%报1.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2564235913","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564235913?lang=zh_cn&edition=full","pubTime":"2025-09-02 21:36","pubTimestamp":1756820188,"startTime":"0","endTime":"0","summary":"北京时间2025年09月02日21时36分，莱斯康制药股票出现波动，股价大幅上涨5.91%。截至发稿，该股报1.17美元/股，成交量51.7541万股，换手率0.14%，振幅4.09%。莱斯康制药股票所在的生物技术行业中，整体涨幅为0.64%。公司的一些候选药物是LX9211，一种口服小分子候选药物，同时也在开发LX9851，另一种口服小分子候选药物，用于治疗肥胖和相关的心脏代谢。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250902213629a70bb85f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250902213629a70bb85f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LXRX","BK4139"],"gpt_icon":0},{"id":"1123212761","title":"在欧洲心脏病学会(ESC) 2025年大会上发布的数据显示，索格列净在各年龄段（包括75岁以上）心力衰竭和主要心血管事件方面提供一致的相对风险降低效果","url":"https://stock-news.laohu8.com/highlight/detail?id=1123212761","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123212761?lang=zh_cn&edition=full","pubTime":"2025-09-02 20:30","pubTimestamp":1756816252,"startTime":"0","endTime":"0","summary":"在欧洲心脏病学会(ESC) 2025年大会上发布的数据显示，索格列净在各年龄段（包括75岁以上）心力衰竭和主要心血管事件方面提供一致的相对风险降低效果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LXRX"],"gpt_icon":0},{"id":"2557857327","title":"莱斯康制药盘中异动 早盘大幅下挫5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557857327","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557857327?lang=zh_cn&edition=full","pubTime":"2025-08-08 23:05","pubTimestamp":1754665518,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日23时05分，莱斯康制药股票出现异动，股价大幅跳水5.36%。截至发稿，该股报1.06美元/股，成交量148.504万股，换手率0.41%，振幅8.04%。机构评级方面，在所有5家参与评级的机构中，60%的券商给予买入建议，40%的券商给予持有建议，无券商给予卖出建议。莱斯康制药股票所在的生物技术行业中，整体跌幅为0.83%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080823051894d7f211&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080823051894d7f211&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LXRX","BK4139"],"gpt_icon":0},{"id":"2557617569","title":"莱斯康制药盘中异动 早盘急速拉升5.15%报1.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557617569","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557617569?lang=zh_cn&edition=full","pubTime":"2025-08-07 21:34","pubTimestamp":1754573694,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日21时34分，莱斯康制药股票出现异动，股价快速上涨5.15%。截至发稿，该股报1.21美元/股，成交量34.2746万股，换手率0.09%，振幅2.61%。机构评级方面，在所有4家参与评级的机构中，50%的券商给予买入建议，50%的券商给予持有建议，无券商给予卖出建议。莱斯康制药股票所在的生物技术行业中，整体跌幅为0.02%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508072134549739b2a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508072134549739b2a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LXRX","BK4139"],"gpt_icon":0},{"id":"2557538640","title":"美股财报 | 莱斯康制药发布Q2财报 前半年累计净亏损同比缩小78.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557538640","media":"同花顺iNews","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557538640?lang=zh_cn&edition=full","pubTime":"2025-08-07 12:00","pubTimestamp":1754539216,"startTime":"0","endTime":"0","summary":"莱斯康制药发布Q2财报，2025财年前六月累计收入3012.80万美元，去年同期累计收入为277.70万美元，同比增长984.91%。2025财年前六月累计净亏损2204.30万美元，去年同期累计净亏损为1.02亿美元，同比缩小78.35%。公司所属行业为生物科技。Lexicon Pharmaceuticals, Inc.是一家生物制药公司，专注于研究并实现人类疾病在治疗上的突破。对于那些被认定有很高药用价值的靶标，其致力于对潜在新药物的研制计划。该公司于1995年7月7日在美国特拉华州成立，并于1995年9月开始营运。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807120604a6d7e0da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807120604a6d7e0da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LXRX"],"gpt_icon":1},{"id":"2557370985","title":"莱斯康制药盘中异动 股价大涨8.38%报1.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557370985","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557370985?lang=zh_cn&edition=full","pubTime":"2025-08-06 21:32","pubTimestamp":1754487174,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日21时32分，莱斯康制药股票出现波动，股价快速上涨8.38%。截至发稿，该股报1.14美元/股，成交量43.4457万股，换手率0.12%，振幅2.85%。莱斯康制药股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Biomx Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、诺瓦瓦克斯医药涨幅较大，Bioxcel Therapeutics, Inc.、Biomx Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为329.41%、277.36%、14.14%，振幅较大的相关个股有Biomx Inc.、Fractyl Health, Inc.、Sutro Biopharma, Inc.，振幅分别为13.47%、9.36%、8.06%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806213254a478d8bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806213254a478d8bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LXRX"],"gpt_icon":0},{"id":"2556380999","title":"莱斯康制药盘中异动 早盘股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556380999","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556380999?lang=zh_cn&edition=full","pubTime":"2025-08-04 22:39","pubTimestamp":1754318345,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日22时39分，莱斯康制药股票出现波动，股价急速拉升5.14%。截至发稿，该股报1.13美元/股，成交量53.8073万股，换手率0.15%，振幅4.67%。莱斯康制药股票所在的生物技术行业中，整体涨幅为0.67%。其相关个股中，Psyence Biomedical Ltd.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、凯信远达涨幅较大，Psyence Biomedical Ltd.、Soligenix, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为5146.65%、1320.35%、512.07%，振幅较大的相关个股有凯信远达、Psyence Biomedical Ltd.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为92.95%、77.54%、46.03%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804223905a474aae1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804223905a474aae1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LXRX","BK4139"],"gpt_icon":0},{"id":"2555002946","title":"莱斯康制药盘中异动 快速下挫5.14%报1.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555002946","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555002946?lang=zh_cn&edition=full","pubTime":"2025-07-31 03:04","pubTimestamp":1753902263,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日03时04分，莱斯康制药股票出现异动，股价快速跳水5.14%。截至发稿，该股报1.02美元/股，成交量115.507万股，换手率0.32%，振幅6.63%。机构评级方面，在所有4家参与评级的机构中，50%的券商给予买入建议，50%的券商给予持有建议，无券商给予卖出建议。莱斯康制药股票所在的生物技术行业中，整体涨幅为0.16%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073103042394c474a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073103042394c474a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LXRX"],"gpt_icon":0},{"id":"2555514068","title":"莱斯康制药盘中异动 大幅下挫5.41%报1.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555514068","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555514068?lang=zh_cn&edition=full","pubTime":"2025-07-29 23:42","pubTimestamp":1753803720,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日23时42分，莱斯康制药股票出现异动，股价快速跳水5.41%。截至发稿，该股报1.03美元/股，成交量84.3107万股，换手率0.23%，振幅3.67%。机构评级方面，在所有4家参与评级的机构中，50%的券商给予买入建议，50%的券商给予持有建议，无券商给予卖出建议。莱斯康制药股票所在的生物技术行业中，整体涨幅为0.21%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729234200a6c81e35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729234200a6c81e35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LXRX","BK4139"],"gpt_icon":0},{"id":"2554109770","title":"莱斯康制药盘中异动 快速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554109770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554109770?lang=zh_cn&edition=full","pubTime":"2025-07-28 22:45","pubTimestamp":1753713924,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日22时45分，莱斯康制药股票出现异动，股价大幅下挫5.00%。截至发稿，该股报1.05美元/股，成交量115.639万股，换手率0.32%，振幅8.18%。机构评级方面，在所有4家参与评级的机构中，50%的券商给予买入建议，50%的券商给予持有建议，无券商给予卖出建议。莱斯康制药股票所在的生物技术行业中，整体涨幅为0.03%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072822452594bf8a1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072822452594bf8a1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LXRX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lexpharma.com","stockEarnings":[{"period":"1week","weight":-0.084},{"period":"1month","weight":-0.1946},{"period":"3month","weight":0.1009},{"period":"6month","weight":0.6097},{"period":"1year","weight":0.5586},{"period":"ytd","weight":0.6249}],"compareEarnings":[{"period":"1week","weight":-0.0061},{"period":"1month","weight":0.0103},{"period":"3month","weight":0.0299},{"period":"6month","weight":0.1363},{"period":"1year","weight":0.1188},{"period":"ytd","weight":0.1583}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lexicon Pharmaceuticals, Inc.是一家生物制药公司，专注于研究并实现人类疾病在治疗上的突破。通过基因敲除技术和先进的医疗技术综合平台，该公司已经系统研究了小白鼠体内近5000个基因的生理和行为功能，且评估了由相应的人类基因作为潜在药物靶标所编码的蛋白质的效用，并且已经在活体（或活的有机体）内确定并验证了100多个能很好地应用于药物发现的靶标。对于那些被认定有很高药用价值的靶标，其致力于对潜在新药物的研制计划。该公司于1995年7月7日在美国特拉华州成立，并于1995年9月开始营运。","yearOnYearQuotes":[{"month":1,"riseRate":0.52,"avgChangeRate":0.042172},{"month":2,"riseRate":0.4,"avgChangeRate":-0.059177},{"month":3,"riseRate":0.48,"avgChangeRate":-0.019425},{"month":4,"riseRate":0.44,"avgChangeRate":0.012763},{"month":5,"riseRate":0.5,"avgChangeRate":0.029091},{"month":6,"riseRate":0.653846,"avgChangeRate":0.134775},{"month":7,"riseRate":0.5,"avgChangeRate":0.021487},{"month":8,"riseRate":0.269231,"avgChangeRate":-0.025279},{"month":9,"riseRate":0.346154,"avgChangeRate":0.011129},{"month":10,"riseRate":0.538462,"avgChangeRate":-0.006481},{"month":11,"riseRate":0.384615,"avgChangeRate":-0.041818},{"month":12,"riseRate":0.461538,"avgChangeRate":0.063503}],"exchange":"NASDAQ","name":"莱斯康制药","nameEN":"Lexicon Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"莱斯康制药(LXRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供莱斯康制药(LXRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"莱斯康制药,LXRX,莱斯康制药股票,莱斯康制药股票老虎,莱斯康制药股票老虎国际,莱斯康制药行情,莱斯康制药股票行情,莱斯康制药股价,莱斯康制药股市,莱斯康制药股票价格,莱斯康制药股票交易,莱斯康制药股票购买,莱斯康制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"莱斯康制药(LXRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供莱斯康制药(LXRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}